LoadingLoadingLoadingThe quick read
Latest quote·Oct 9
Net buying: insiders sold $0 and bought $64K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet buying: insiders sold $0 and bought $64K of CBK stock on the open market in the 90 days to Oct 13, 2026, according to SEC Form 4 filings. The largest was Metheny, Philip J. (EVP, Chief Financial Officer), who bought $61K. The latest filing was on Sep 28, 2026.
None. No member of Congress disclosed a CBK trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net buying.
Buys (3)
Robertson John Adam
$2K
bought
Metheny Philip J.
$27K
bought
Metheny Philip J.
$5K
bought
No tracked top-trader positions in CBK right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Jul 27, 2026
Period ending
Jun 30, 2026
Adjusted EPS
$0.70 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 27, 2026 | $0.75 / $0.70Yahoo Finance | +7.14% beat | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 27, 2026 | $0.73 / $0.68Yahoo Finance | +7.35% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Jan 26, 2026 | $0.72 / $0.67Yahoo Finance | +7.46% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 28, 2025 | $0.77 / $0.82Yahoo Finance | -6.10% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Sep 3, 2025 | Unavailable | - | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $32.6M | $32.6M | $30.8M | $32.8M |
| Cost of what it sold | $9.8M | $9.3M | $9.1M | $9.0M |
| Gross profit | $22.8M | $23.3M | $21.7M | $23.8M |
| What it spent | ||||
| Sales and admin | $6.0M | $6.5M | $6.6M | $6.5M |
| Other operating costs | $4.5M | $4.1M | $3.3M | $4.3M |
| Total operating expenses | $10.5M | $10.6M | $9.9M | $10.9M |
| What was left | ||||
| Operating profit | $12.3M | $12.7M | $11.9M | $12.9M |
| Interest on debt | $9.8M | $9.1M | $9.0M | $8.6M |
| Profit before tax | $12.3M | $12.7M | $11.9M | $12.9M |
| Tax | $2.8M | $2.8M | $2.3M | $2.7M |
| Net profit | $9.5M | $9.9M | $9.5M | $10.2M |
| EBITDA | $13.0M | $14.9M | $12.7M | $12.9M |
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
